empty

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections caused by aerobic Gram-negative bacteria. Zavicefta combines the beta-lactam antibiotic ceftazidime with the beta-lactamase inhibitor, avibactam.

Pfizer says that ceftazidime-avibactam is effective against some “resistant aerobic Gram-negative pathogens of greatest global concern”, such as carbapenem-resistant Enterobacteriaceae and multi-drug resistant Pseudomonas aeruginosa.

Recommended

Clinical review: Antihypertensive medication

NICE recommends Tremfya




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.